ID: ALA189110

Max Phase: Preclinical

Molecular Formula: C22H22ClF3O5

Molecular Weight: 458.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@@]1(C(=O)O)Cc2cc(OCCCOc3ccc(CC(F)(F)F)cc3Cl)ccc2O1

Standard InChI:  InChI=1S/C22H22ClF3O5/c1-2-21(20(27)28)13-15-11-16(5-7-18(15)31-21)29-8-3-9-30-19-6-4-14(10-17(19)23)12-22(24,25)26/h4-7,10-11H,2-3,8-9,12-13H2,1H3,(H,27,28)/t21-/m0/s1

Standard InChI Key:  IUZYEVSRBUMFHK-NRFANRHFSA-N

Associated Targets(Human)

Peroxisome proliferator-activated receptor delta 6293 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Peroxisome proliferator-activated receptor gamma 15191 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Peroxisome proliferator-activated receptor alpha 9197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cricetinae gen. sp. 3197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Peroxisome proliferator-activated receptor alpha 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 458.86Molecular Weight (Monoisotopic): 458.1108AlogP: 5.46#Rotatable Bonds: 9
Polar Surface Area: 64.99Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.43CX Basic pKa: CX LogP: 5.80CX LogD: 2.40
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: -0.15

References

1. Shi GQ, Dropinski JF, Zhang Y, Santini C, Sahoo SP, Berger JP, Macnaul KL, Zhou G, Agrawal A, Alvaro R, Cai TQ, Hernandez M, Wright SD, Moller DE, Heck JV, Meinke PT..  (2005)  Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity.,  48  (17): [PMID:16107159] [10.1021/jm050373g]

Source